Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 5

Comparison of SARS-COV-2 antibody assays in PCR negative and PCR positive Turkish patients

Pages
2795–2797
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

SARINOĞLU, R. C., KORTEN, V., KARAHASAN, A., BİLGİN, H., ÇİMSİT, N. C., CAN, B. (2022). Comparison of SARS-COV-2 antibody assays in PCR negative and PCR positive Turkish patients. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 5, 2795–2797. https://ajindex.com/articles/609531

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Vauloup-Fellous C, Maylin S, Périllaud-Dubois C, Brichler S, Alloui C et al. Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients. European Journal of Clinical Microbiology and Infectious Diseases 2021; 29:1–7. doi: 10.1007/s10096-021-04232-3 2. Hanson KE, Caliendo AM, Arias CA, Englund JA, Hayden MK et al. Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing. Clinical Infectious Diseases 2020; 12:ciaa1343. doi: 10.1093/cid/ciaa1343 3. Huang AT, Garcia-Carreras B, Hitchings MDT, Yang B, Katzelnick LC et al. A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity. Nature Communications 2020; 17; 11(1):4704. doi: 10.1038/s41467-020-18450-4 4. Sayinalp B, Çinar OE, Haznedaroğlu İC. Perspectives for immune plasma treatment of COVID-19. Turkish Journal of Medical Sciences 2021; 51(1):1-9. doi: 10.3906/sag-2005-410 5. Zhao J, Yuan Q, Wang H, Liu W, Liao X et al. Antibody Responses to SARS-CoV-2 in patients with novel coronavirus disease 2019. Clinical Infectious Diseases 2020; 19; 71(16):2027- 2034. doi: 10.1093/cid/ciaa344 6. Peeling R, Wedderburn C, Garcia P, Boeras D, Fongwen N et al. Serology testing in the COVID-19 pandemic response. Lancet Infectious Diseases 2020; 20(9): e245–e249. doi: 10.1016/ S1473-3099(20)30517-X 7. Sterlin D, Mathian A, Miyara M,Mohr A, Anna F et al. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Science Translational Medicine 2021; 20; 13(577):eabd2223. doi: 10.1126/scitranslmed.abd2223 8. Mei S, Brett Case J, Franks C, Chen RE, Anderson NW et al. Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays. Clinical Chemistry 2020; 1538–1547. Sep 7:hvaa211. doi: 10.1093/clinchem/hvaa211 9. Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Spijker R et al. Cochrane COVID-19 diagnostic test accuracy group. antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database Systematic Review 2020; 25; 6(6):CD013652. doi: 10.1002/14651858.CD013652 10. Beavis KG, Matushek SM, Abeleda APF, Bethel C, Hunt Cet al. Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA assay for detection of IgA and IgG antibodies. Journal of Clinical Virology 2020;129:104468. doi: 10.1016/j. jcv.2020.104468 11. Hanssen DAT, Slaats M, Mulder M, Savelkoul PHM, van Loo IHM. Evaluation of 18 commercial serological assay